Featured

• • 

    

    Peter Libby, MD

    Peer

  • 

    

    Lawrence A. Leiter, MD

    Peer

  • 

    

    Prof. Kausik Ray, MBChB, MD, MPhil

    Peer

  7

  

  RestartResume

  Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction

  RestartResume

  Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction

  0.25 credits

  Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASC…

  0.25 credits

• • 

    

    Peter Rossing, DMSc, MD

    Peer

  • 

    

    Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)

    Peer

  • 

    

    Matthew R. Weir, MD

    Peer

  10

  

  RestartResume

  New Insights into the Management of CKD in T2D: The Role of MRA Therapies

  RestartResume

  New Insights into the Management of CKD in T2D: The Role of MRA Therapies

  0.25 credits

  New Insights into the Management of CKD in T2D: The Role of MRA Therapies

  0.25 credits

• • 

    

    Mikhail Kosiborod, MD

    Peer

  • 

    

    Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI

    Peer

  12

  

  RestartResume

  New Perspectives in Managing HF and HK – The Cardiorenal Angle

  RestartResume

  New Perspectives in Managing HF and HK – The Cardiorenal Angle

  0.25 credits

  New Perspectives in Managing HF and HK – The Cardiorenal Angle

  0.25 credits

• • 

    

    Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  5

  CME/CE Broadcast Replay

  

  RestartResume

  Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction

  RestartResume

  Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction

  1.00 credits

  Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction

  1.00 credits